Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong
· Delayed Price · Currency is HKD 0.1500
0.00 (0.00%)
May 26, 2025, 10:12 AM HKT
Tianda Pharmaceuticals Revenue
In the year 2024, Tianda Pharmaceuticals had annual revenue of 329.94M HKD, down -37.99%. Tianda Pharmaceuticals had revenue of 173.86M in the half year ending December 31, 2024, a decrease of -30.41%.
Revenue
329.94M
Revenue Growth
-37.99%
P/S Ratio
0.98
Revenue / Employee
470.67K
Employees
701
Market Cap
322.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 329.94M | -202.15M | -37.99% |
| Dec 31, 2023 | 532.09M | -14.61M | -2.67% |
| Dec 31, 2022 | 546.69M | 36.74M | 7.20% |
| Mar 31, 2022 | 509.96M | 35.62M | 7.51% |
| Mar 31, 2021 | 474.33M | -17.14M | -3.49% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| CSPC Pharmaceutical Group | 30.87B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |